ImExHS First Half 2023 Earnings: AU$0.055 loss per share (vs AU$0.053 loss in 1H 2022)
ImExHS (ASX:IME) First Half 2023 Results
Key Financial Results
Revenue: AU$8.86m (down 7.5% from 1H 2022).
Net loss: AU$2.29m (loss widened by 31% from 1H 2022).
AU$0.055 loss per share (further deteriorated from AU$0.053 loss in 1H 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
ImExHS Earnings Insights
Looking ahead, revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Healthcare Services industry in Australia.
Performance of the Australian Healthcare Services industry.
The company's shares are up 5.8% from a week ago.
Risk Analysis
You still need to take note of risks, for example - ImExHS has 4 warning signs (and 1 which makes us a bit uncomfortable) we think you should know about.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
